Seattle-based Cyrus Biotechnology says it’ll collaborate with the Broad Institute of MIT and Harvard on ways to optimize CRISPR gene-editing… Read More
The Seattle Children’s Research Institute announced Wednesday that it has licensed a new gene therapy technology to Cambridge, Mass.,-based biotech company… Read More